Recruiting Myasthenia Gravis Studies in Paris
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: ...
Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG....
About Myasthenia Gravis Clinical Trials in Paris
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.
There are currently 2 myasthenia gravis clinical trials recruiting participants in Paris, PARIS. These studies are seeking a combined 24 participants. Research is being sponsored by argenx, Alexion Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myasthenia Gravis Clinical Trials in Paris — FAQ
Are there myasthenia gravis clinical trials in Paris?
Yes, there are 2 myasthenia gravis clinical trials currently recruiting in Paris, PARIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Paris?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Paris research site will contact you about next steps.
Are clinical trials in Paris free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Paris studies also compensate for your time and travel.
What myasthenia gravis treatments are being tested?
The 2 active trials in Paris are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.
Data updated March 2, 2026 from ClinicalTrials.gov